AI Summary
✦ ClarthaValuation Metrics
Forward Valuation Outlook
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
Historical valuation metrics are unavailable for this ticker right now.
Peers & Comparison
Sector: Healthcare · Theme: Biotechnology
Biotechnology Peers5 peers
Avg P/E: 96.5x| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
BIOCON LIMITED. BIOCONBiotechnology | +10.0% | 2.9% | 124.9x Premium | +29% vs avg | +20.1% |
ANTHEM BIOSCIENCES LTD ANTHEMBiotechnology | -22.6% | 28.7% | 84.0x Fair | -13% vs avg | +18.1% |
SAI LIFE SCIENCES LIMITED SAILIFEBiotechnology | +11.7% | 16.1% | 84.0x Fair | -13% vs avg | +60.0% |
ACUTAAS CHEMICALS LIMITED ACUTAASBiotechnology | +59.1% | 26.4% | 93.3x Fair | -3% vs avg | +149.2% |
ONESOURCE SPECL PHARMA L ONESOURCEBiotechnology | +37.2% | -3.1% | — | — | -16.9% |
WHY THESE PEERS
Sheel Biotech Limited is compared against the Biotechnology cohort. Peers include BIOCON LIMITED., ANTHEM BIOSCIENCES LTD, SAI LIFE SCIENCES LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.